| UniProt ID | CTC1_HUMAN | |
|---|---|---|
| UniProt AC | Q2NKJ3 | |
| Protein Name | CST complex subunit CTC1 | |
| Gene Name | CTC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1217 | |
| Subcellular Localization |
Nucleus . Chromosome, telomere . A transmembrane region is predicted by sequence analysis tools (ESKW, MEMSAT and Phobius) however, given the telomeric localization of the protein, the relevance of the transmembrane region is unsure in vivo. |
|
| Protein Description | Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation. [PubMed: 19854130 However, the CST complex has been shown to be involved in several aspects of telomere replication. The CST complex inhibits telomerase and is involved in telomere length homeostasis; it is proposed to bind to newly telomerase-synthesized 3' overhangs and to terminate telomerase action implicating the association with the ACD:POT1 complex thus interfering with its telomerase stimulation activity. The CST complex is also proposed to be involved in fill-in synthesis of the telomeric C-strand probably implicating recruitment and activation of DNA polymerase alpha] | |
| Protein Sequence | MAAGRAQVPSSEQAWLEDAQVFIQKTLCPAVKEPNVQLTPLVIDCVKTVWLSQGRNQGSTLPLSYSFVSVQDLKTHQRLPCCSHLSWSSSAYQAWAQEAGPNGNPLPREQLLLLGTLTDLSADLEQECRNGSLYVRDNTGVLSCELIDLDLSWLGHLFLFPRWSYLPPARWNSSGEGHLELWDAPVPVFPLTISPGPVTPIPVLYPESASCLLRLRNKLRGVQRNLAGSLVRLSALVKSKQKAYFILSLGRSHPAVTHVSIIVQVPAQLVWHRALRPGTAYVLTELRVSKIRGQRQHVWMTSQSSRLLLLKPECVQELELELEGPLLEADPKPLPMPSNSEDKKDPESLVRYSRLLSYSGAVTGVLNEPAGLYELDGQLGLCLAYQQFRGLRRVMRPGVCLQLQDVHLLQSVGGGTRRPVLAPCLRGAVLLQSFSRQKPGAHSSRQAYGASLYEQLVWERQLGLPLYLWATKALEELACKLCPHVLRHHQFLQHSSPGSPSLGLQLLAPTLDLLAPPGSPVRNAHNEILEEPHHCPLQKYTRLQTPSSFPTLATLKEEGQRKAWASFDPKALLPLPEASYLPSCQLNRRLAWSWLCLLPSAFCPAQVLLGVLVASSHKGCLQLRDQSGSLPCLLLAKHSQPLSDPRLIGCLVRAERFQLIVERDVRSSFPSWKELSMPGFIQKQQARVYVQFFLADALILPVPRPCLHSATPSTPQTDPTGPEGPHLGQSRLFLLCHKEALMKRNFCVPPGASPEVPKPALSFYVLGSWLGGTQRKEGTGWGLPEPQGNDDNDQKVHLIFFGSSVRWFEFLHPGQVYRLIAPGPATPMLFEKDGSSCISRRPLELAGCASCLTVQDNWTLELESSQDIQDVLDANKSLPESSLTDLLSDNFTDSLVSFSAEILSRTLCEPLVASLWMKLGNTGAMRRCVKLTVALETAECEFPPHLDVYIEDPHLPPSLGLLPGARVHFSQLEKRVSRSHNVYCCFRSSTYVQVLSFPPETTISIPLPHIYLAELLQGGQSPFQATASCHIVSVFSLQLFWVCAYCTSICRQGKCTRLGSTCPTQTAISQAIIRLLVEDGTAEAVVTCRNHHVAAALGLCPREWASLLDFVQVPGRVVLQFAGPGAQLESSARVDEPMTMFLWTLCTSPSVLRPIVLSFELERKPSKIVPLEPPRLQRFQCGELPFLTHVNPRLRLSCLSIRESEYSSSLGILASSC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Ubiquitination | DAQVFIQKTLCPAVK HHHHHHHHHCCHHHC | 38.35 | 29967540 | |
| 32 | Ubiquitination | KTLCPAVKEPNVQLT HHCCHHHCCCCCCCC | 70.34 | 29967540 | |
| 47 | Ubiquitination | PLVIDCVKTVWLSQG HHHHHHHEEEEECCC | 43.63 | - | |
| 74 (in isoform 2) | Ubiquitination | - | 52.85 | 21906983 | |
| 74 (in isoform 1) | Ubiquitination | - | 52.85 | 21906983 | |
| 74 | Ubiquitination | FVSVQDLKTHQRLPC EEEHHHCCCCCCCCC | 52.85 | 21906983 | |
| 132 | Phosphorylation | EQECRNGSLYVRDNT HHHHHCCCEEEECCC | 21.78 | 24719451 | |
| 238 | Ubiquitination | VRLSALVKSKQKAYF HHHHHHHHCCCCEEE | 53.43 | 21906983 | |
| 238 (in isoform 1) | Ubiquitination | - | 53.43 | 21906983 | |
| 240 | Ubiquitination | LSALVKSKQKAYFIL HHHHHHCCCCEEEEE | 50.53 | 22817900 | |
| 242 | Ubiquitination | ALVKSKQKAYFILSL HHHHCCCCEEEEEEC | 49.11 | 22817900 | |
| 257 | Ubiquitination | GRSHPAVTHVSIIVQ CCCCCCCCEEEEEEE | 20.75 | 22817900 | |
| 374 | Ubiquitination | NEPAGLYELDGQLGL CCCCCEEEECCHHHH | 45.48 | 22817900 | |
| 477 | Ubiquitination | ATKALEELACKLCPH HHHHHHHHHHHHCHH | 5.04 | 22817900 | |
| 480 | Ubiquitination | ALEELACKLCPHVLR HHHHHHHHHCHHHHH | 47.74 | 29967540 | |
| 496 | Ubiquitination | HQFLQHSSPGSPSLG HHHHCCCCCCCCCHH | 31.02 | 22817900 | |
| 513 | Ubiquitination | LLAPTLDLLAPPGSP HHHHHHHHHCCCCCC | 5.03 | 22817900 | |
| 519 | Phosphorylation | DLLAPPGSPVRNAHN HHHCCCCCCCCCCCH | 26.46 | 26329039 | |
| 521 | Ubiquitination | LAPPGSPVRNAHNEI HCCCCCCCCCCCHHH | 8.69 | 22817900 | |
| 521 (in isoform 2) | Ubiquitination | - | 8.69 | 21906983 | |
| 539 | Ubiquitination | PHHCPLQKYTRLQTP CCCCCCHHCCCCCCC | 57.16 | 29967540 | |
| 540 | Phosphorylation | HHCPLQKYTRLQTPS CCCCCHHCCCCCCCC | 5.55 | 22468782 | |
| 545 | Phosphorylation | QKYTRLQTPSSFPTL HHCCCCCCCCCCCCH | 29.72 | 22468782 | |
| 556 (in isoform 1) | Ubiquitination | - | 49.73 | 21906983 | |
| 556 | Ubiquitination | FPTLATLKEEGQRKA CCCHHHHHHHCCCCH | 49.73 | 21906983 | |
| 562 | Ubiquitination | LKEEGQRKAWASFDP HHHHCCCCHHHCCCH | 40.15 | 29967540 | |
| 580 | Phosphorylation | LPLPEASYLPSCQLN CCCCCHHHCCCCHHH | 29.67 | 18452278 | |
| 583 | Phosphorylation | PEASYLPSCQLNRRL CCHHHCCCCHHHHHH | 16.35 | 18452278 | |
| 630 | Ubiquitination | LRDQSGSLPCLLLAK HHCCCCCCCEEEEEC | 3.86 | 22817900 | |
| 637 | Ubiquitination | LPCLLLAKHSQPLSD CCEEEEECCCCCCCC | 43.70 | - | |
| 638 | Ubiquitination | PCLLLAKHSQPLSDP CEEEEECCCCCCCCH | 26.51 | 22817900 | |
| 638 (in isoform 2) | Ubiquitination | - | 26.51 | 21906983 | |
| 673 | Ubiquitination | RSSFPSWKELSMPGF HHCCCCHHHHCCCCC | 53.79 | 22817900 | |
| 673 (in isoform 1) | Ubiquitination | - | 53.79 | 21906983 | |
| 675 | Ubiquitination | SFPSWKELSMPGFIQ CCCCHHHHCCCCCCH | 4.76 | 22817900 | |
| 683 | Ubiquitination | SMPGFIQKQQARVYV CCCCCCHHHHHHHHH | 39.29 | - | |
| 689 | Phosphorylation | QKQQARVYVQFFLAD HHHHHHHHHHHHHCC | 5.29 | 28348404 | |
| 709 | Phosphorylation | VPRPCLHSATPSTPQ CCCCCCCCCCCCCCC | 22.38 | 23312004 | |
| 711 | Phosphorylation | RPCLHSATPSTPQTD CCCCCCCCCCCCCCC | 22.31 | 23312004 | |
| 713 | Phosphorylation | CLHSATPSTPQTDPT CCCCCCCCCCCCCCC | 48.65 | 23312004 | |
| 714 | Phosphorylation | LHSATPSTPQTDPTG CCCCCCCCCCCCCCC | 22.18 | 23312004 | |
| 717 | Phosphorylation | ATPSTPQTDPTGPEG CCCCCCCCCCCCCCC | 45.19 | 23312004 | |
| 733 | Ubiquitination | HLGQSRLFLLCHKEA CCCHHHHHHHHHHHH | 4.81 | 22817900 | |
| 741 (in isoform 2) | Ubiquitination | - | 4.33 | 21906983 | |
| 741 | Ubiquitination | LLCHKEALMKRNFCV HHHHHHHHHHCCCCC | 4.33 | 22817900 | |
| 752 | Ubiquitination | NFCVPPGASPEVPKP CCCCCCCCCCCCCCC | 27.90 | 22817900 | |
| 753 | Phosphorylation | FCVPPGASPEVPKPA CCCCCCCCCCCCCCC | 27.75 | 25159151 | |
| 760 | Ubiquitination | SPEVPKPALSFYVLG CCCCCCCCEEEEEEE | 23.20 | 22817900 | |
| 760 (in isoform 2) | Ubiquitination | - | 23.20 | 21906983 | |
| 776 | Ubiquitination | WLGGTQRKEGTGWGL HHCCCCCCCCCCCCC | 51.16 | 21906983 | |
| 776 (in isoform 1) | Ubiquitination | - | 51.16 | 21906983 | |
| 795 | Ubiquitination | GNDDNDQKVHLIFFG CCCCCCCEEEEEEEC | 34.19 | 22817900 | |
| 795 (in isoform 1) | Ubiquitination | - | 34.19 | 21906983 | |
| 835 | Phosphorylation | MLFEKDGSSCISRRP EEEECCCCCCCCCCC | 31.97 | 29262532 | |
| 836 | Phosphorylation | LFEKDGSSCISRRPL EEECCCCCCCCCCCH | 22.47 | 29262532 | |
| 839 | Phosphorylation | KDGSSCISRRPLELA CCCCCCCCCCCHHHC | 26.94 | 29262532 | |
| 904 | Phosphorylation | SFSAEILSRTLCEPL HHCHHHHHHHCCHHH | 28.96 | 24719451 | |
| 918 | Ubiquitination | LVASLWMKLGNTGAM HHHHHHHHHCCCHHH | 41.48 | - | |
| 931 | Ubiquitination | AMRRCVKLTVALETA HHHHHHHHEEEEEEE | 2.02 | 22817900 | |
| 939 | Ubiquitination | TVALETAECEFPPHL EEEEEEEECCCCCCE | 41.84 | 22817900 | |
| 939 (in isoform 2) | Ubiquitination | - | 41.84 | 21906983 | |
| 974 (in isoform 1) | Ubiquitination | - | 67.69 | 21906983 | |
| 974 | Ubiquitination | VHFSQLEKRVSRSHN EEHHHHHHHHHHCCC | 67.69 | 27667366 | |
| 1060 | Phosphorylation | GKCTRLGSTCPTQTA CCCCCCCCCCCCHHH | 31.28 | - | |
| 1064 | Phosphorylation | RLGSTCPTQTAISQA CCCCCCCCHHHHHHH | 40.47 | - | |
| 1066 | Phosphorylation | GSTCPTQTAISQAII CCCCCCHHHHHHHHH | 28.56 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of CTC1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612199 | Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...